{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T00:08:35Z","timestamp":1793578115317,"version":"4.5.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"EDCTP2 programme supported by the European Union"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Malaria remains the leading cause of morbidity and mortality in Ghana, particularly in rural high-burden communities. Mass drug administration (MDA) has re-emerged as a complementary strategy to reduce transmission, yet community acceptability and implementation challenges remain underexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a cross-sectional study in the Pokrom subdistrict following pilot mass drug administration (MDA) interventions. Data were collected through eleven focus group discussions (FGDs), nine with community members and two with healthcare providers, comprising 97 participants, as well as eight in-depth interviews (IDIs) with assemblymen, healthcare providers and personnel of malaria elimination programme. Thes were complemented by field notes. Participants were purposively selected from individuals who had participated in the MDA interventions and provided informed consent. This study explored community perceptions of malaria burden, perceived MDA effectiveness, reported adverse events, health-seeking behaviour, financial implications and acceptability. Transcripts were analysed thematically using a hybrid inductive\u2013deductive approach informed by reflexive thematic analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Malaria was widely identified as the most pressing health concern in the subdistrict prior to the MDA intervention, with frequent hospitalisation and substantial household expenditure on treatment reported. Following the MDA interventions, notable reductions in malaria episodes were described, with some households transitioning from frequent infections to rare or no illness. These perceived improvements were accompanied by decreased healthcare-related costs, indicating important financial and economic benefits. Though adverse events, including dizziness, abdominal pain, and weakness, were reported, they were generally perceived as mild and transient. Initial challenges included inadequate community sensitization and negative messaging from some health workers, which temporarily affected uptake. Despite these concerns, willingness to participate in future MDA rounds remained high among community members, with recommendations emphasizing continued sensitization, strengthened drug delivery systems, and enhanced monitoring of side effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The MDA interventions were widely perceived as beneficial in reducing malaria burden and associated household healthcare costs in rural Ghana. Consistent with the Theoretical Framework of Acceptability, perceived effectiveness and economic benefits outweighed the burden of transient adverse events, contributing to perceived high community acceptability. Strengthening communication, pharmacovigilance, and community engagement could be critical for sustaining uptake and supporting the potential scale-up of MDA in high-burden malaria settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12936-026-05979-w","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T02:45:18Z","timestamp":1781059518000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Community perspective on feasibility of malaria mass drug administration: a qualitative evidence from the Eastern Region of Ghana"],"prefix":"10.1186","volume":"25","author":[{"given":"Ignatius Cheng","family":"Ndong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuo Ennestine","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ndong Henry","family":"Ndang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collins Attuah","family":"Baah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Asumah","family":"Adu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Amponsah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana Yaw","family":"Peprah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keziah","family":"Malm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olumide","family":"Ogundahunsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collins Stephen","family":"Ahorlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Amambua-Ngwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"5979_CR1","volume-title":"WHO malaria policy advisory group (MPAG) meeting report, 18\u201320 April 2023","author":"Organization, W.H.","year":"2023","unstructured":"Organization, W.H. WHO malaria policy advisory group (MPAG) meeting report, 18\u201320 April 2023. World Health Organization; 2023."},{"issue":"1","key":"5979_CR2","doi-asserted-by":"publisher","DOI":"10.1080\/21665095.2025.2481830","volume":"12","author":"E Nketiah-Amponsah","year":"2025","unstructured":"Nketiah-Amponsah E, Adjotor FN. The impact of malaria-related expenditures on malaria incidence and mortality rates in Sub-Saharan Africa (SSA). Dev Stud Res. 2025;12(1):2481830.","journal-title":"Dev Stud Res"},{"key":"5979_CR3","volume-title":"WHO malaria policy advisory group (MPAG) meeting report, 4, 5 and 7 March 2024","author":"Organization, W.H.","year":"2024","unstructured":"Organization, W.H. WHO malaria policy advisory group (MPAG) meeting report, 4, 5 and 7 March 2024. World Health Organization; 2024."},{"issue":"7572","key":"5979_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature15535","volume":"526","author":"S Bhatt","year":"2015","unstructured":"Bhatt S, et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature. 2015;526(7572):207\u201311.","journal-title":"Nature"},{"key":"5979_CR5","unstructured":"Ministry of Health, G.H.S., National Malaria Control Programme. , Guidelines for Case Management of Malaria in Ghana. 2020. 4th Edn. Accra, Ghana. 2020."},{"key":"5979_CR6","doi-asserted-by":"crossref","unstructured":"Grant, J., et al., Challenges and lessons learned during the planning and early implementation of the RTS, S\/AS01. 2022.","DOI":"10.1186\/s12936-022-04168-9"},{"key":"5979_CR7","doi-asserted-by":"crossref","unstructured":"Bediako, V.B., et al., Unravelling the predictors of vaccine defaults in Southern Ghana: Evidence from the Malaria RTSS vaccine implementation trial program in the Cape Coast Metropolis. 2024.","DOI":"10.21203\/rs.3.rs-4102992\/v1"},{"issue":"4","key":"5979_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0195533","volume":"13","author":"MA Dalaba","year":"2018","unstructured":"Dalaba MA, et al. Cost of malaria treatment and health seeking behaviour of children under-five years in the Upper West Region of Ghana. PLoS ONE. 2018;13(4):e0195533.","journal-title":"PLoS ONE"},{"key":"5979_CR9","first-page":"1","volume":"4","author":"AS Laar","year":"2013","unstructured":"Laar AS, Laar AK, Dalinjong PA. Community perception of malaria and its influence on health-seeking behaviour in rural Ghana: a descriptive study. MalariaWorld J. 2013;4:1.","journal-title":"MalariaWorld J"},{"issue":"1","key":"5979_CR10","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1186\/s13071-021-04919-8","volume":"14","author":"F Dao","year":"2021","unstructured":"Dao F, et al. Burden of malaria in children under five and caregivers\u2019 health-seeking behaviour for malaria-related symptoms in artisanal mining communities in Ghana. Parasit Vectors. 2021;14(1):418.","journal-title":"Parasit Vectors"},{"issue":"10","key":"5979_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11101118","volume":"11","author":"CS Ahorlu","year":"2022","unstructured":"Ahorlu CS, et al. The effect of mass testing, treatment and tracking on the prevalence of febrile illness in children under 15 in Ghana. Pathogens. 2022;11(10):1118.","journal-title":"Pathogens"},{"issue":"1","key":"5979_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12936-019-2906-8","volume":"18","author":"TP Eisele","year":"2019","unstructured":"Eisele TP. Mass drug administration can be a valuable addition to the malaria elimination toolbox. Malar J. 2019;18(1):281.","journal-title":"Malar J"},{"key":"5979_CR13","volume-title":"Malaria surveillance, monitoring and evaluation: a reference manual","author":"Organization, W.H.","year":"2025","unstructured":"Organization, W.H. Malaria surveillance, monitoring and evaluation: a reference manual. World Health Organization; 2025."},{"issue":"12","key":"5979_CR14","first-page":"Cd008846","volume":"2013","author":"E Poirot","year":"2013","unstructured":"Poirot E, et al. Mass drug administration for malaria. Cochrane Database Syst Rev. 2013;2013(12):Cd008846.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"5979_CR15","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1186\/s12889-019-7986-4","volume":"19","author":"IC Ndong","year":"2019","unstructured":"Ndong IC, et al. Prevalence of asymptomatic malaria parasitaemia following mass testing and treatment in Pakro sub-district of Ghana. BMC Public Health. 2019;19(1):1622.","journal-title":"BMC Public Health"},{"issue":"1","key":"5979_CR16","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s12936-021-03761-8","volume":"20","author":"J Okebe","year":"2021","unstructured":"Okebe J, et al. Reactive, self-administered malaria treatment against asymptomatic malaria infection: results of a cluster randomized controlled trial in The Gambia. Malar J. 2021;20(1):253.","journal-title":"Malar J"},{"issue":"7","key":"5979_CR17","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1093\/cid\/ciz403","volume":"70","author":"MS Hsiang","year":"2020","unstructured":"Hsiang MS, et al. Active case finding for malaria: a 3-year national evaluation of optimal approaches to detect infections and hotspots through reactive case detection in the low-transmission setting of Eswatini. Clin Infect Dis. 2020;70(7):1316\u201325.","journal-title":"Clin Infect Dis"},{"issue":"10233","key":"5979_CR18","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/S0140-6736(20)30470-0","volume":"395","author":"MS Hsiang","year":"2020","unstructured":"Hsiang MS, et al. Effectiveness of reactive focal mass drug administration and reactive focal vector control to reduce malaria transmission in the low malaria-endemic setting of Namibia: a cluster-randomised controlled, open-label, two-by-two factorial design trial. Lancet. 2020;395(10233):1361\u201373.","journal-title":"Lancet"},{"issue":"4 Suppl","key":"5979_CR19","first-page":"17","volume":"110","author":"ZD Schneider","year":"2023","unstructured":"Schneider ZD, et al. Mass drug administration to reduce malaria transmission: A systematic review and meta-analysis. Am J Trop Med Hyg. 2023;110(4 Suppl):17.","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"5979_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1475-2875-13-47","volume":"13","author":"NJ Dial","year":"2014","unstructured":"Dial NJ, et al. A qualitative study to assess community barriers to malaria mass drug administration trials in The Gambia. Malar J. 2014;13(1):47.","journal-title":"Malar J"},{"key":"5979_CR21","unstructured":"Fimbo, A.M., Pharmacovigilance of mass drug administration as preventive chemotherapy to control and eliminate lymphatic filariasis in Tanzania. 2024: Karolinska Institutet (Sweden)."},{"issue":"1","key":"5979_CR22","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12936-024-05078-8","volume":"23","author":"E Legendre","year":"2024","unstructured":"Legendre E, et al. Prospective acceptability of mass drug administration for malaria in Kedougou region in Senegal: a mixed method study. Malar J. 2024;23(1):279.","journal-title":"Malar J"},{"key":"5979_CR23","doi-asserted-by":"publisher","DOI":"10.2147\/RMHP.S468390","author":"D Abdissa","year":"2024","unstructured":"Abdissa D, et al. Effectiveness of integrated social and behavior change communication interventions in mass drug administration campaigns in enhancing knowledge, perceptions, and preventive practices for neglected tropical diseases in Jimma. Risk Manag Healthc Policy. 2024. https:\/\/doi.org\/10.2147\/RMHP.S468390.","journal-title":"Risk Manag Healthc Policy"},{"issue":"2","key":"5979_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-081982","volume":"14","author":"KR Awasthi","year":"2024","unstructured":"Awasthi KR, et al. Community engagement approaches for malaria prevention, control and elimination: a scoping review. BMJ Open. 2024;14(2):e081982.","journal-title":"BMJ Open"},{"issue":"1","key":"5979_CR25","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1186\/s12936-018-2624-7","volume":"17","author":"H Wanzira","year":"2018","unstructured":"Wanzira H, et al. Community facilitators and barriers to a successful implementation of mass drug administration and indoor residual spraying for malaria prevention in Uganda: a qualitative study. Malar J. 2018;17(1):474.","journal-title":"Malar J"},{"issue":"1","key":"5979_CR26","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1186\/s12936-016-1493-1","volume":"15","author":"M Aregawi","year":"2016","unstructured":"Aregawi M, et al. Impact of the mass drug administration for malaria in response to the Ebola outbreak in Sierra Leone. Malar J. 2016;15(1):480.","journal-title":"Malar J"},{"issue":"1","key":"5979_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-019-7037-1","volume":"19","author":"IC Ndong","year":"2019","unstructured":"Ndong IC, et al. Challenges and perceptions of implementing mass testing, treatment and tracking in malaria control: a qualitative study in Pakro sub-district of Ghana. BMC Public Health. 2019;19(1):695.","journal-title":"BMC Public Health"},{"issue":"10","key":"5979_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0275976","volume":"17","author":"CI Ndong","year":"2022","unstructured":"Ndong CI, et al. The impact of COVID-19 on implementation of mass testing, treatment and tracking of malaria in rural communities in Ghana: a qualitative study. PLoS ONE. 2022;17(10):e0275976.","journal-title":"PLoS ONE"},{"key":"5979_CR29","unstructured":"Mugisha Emmanuel, K., Community Engagement and Health Education Programs: Addressing the Intersection of Malaria and Anemia in Africa."},{"issue":"2","key":"5979_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148627","volume":"11","author":"S Dierickx","year":"2016","unstructured":"Dierickx S, et al. Factors associated with non-participation and non-adherence in directly observed mass drug administration for malaria in The Gambia. PLoS ONE. 2016;11(2):e0148627.","journal-title":"PLoS ONE"},{"key":"5979_CR31","first-page":"45","volume":"4","author":"VL Champion","year":"2008","unstructured":"Champion VL, Skinner CS. The health belief model. Health behavior and health education: Theory, research, and practice. 2008;4:45\u201365.","journal-title":"Health behavior and health education: Theory, research, and practice"},{"key":"5979_CR32","unstructured":"GSS, The 2010 Population and Housing Report. Accra. 2011."},{"key":"5979_CR33","unstructured":"International, G.G.M., Ghana Demographic and Health Survey 2014. Accra. 2015."},{"issue":"5","key":"5979_CR34","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10488-013-0528-y","volume":"42","author":"LA Palinkas","year":"2015","unstructured":"Palinkas LA, et al. Purposeful sampling for qualitative data collection and analysis in mixed method implementation research. Adm Policy Ment Health. 2015;42(5):533\u201344.","journal-title":"Adm Policy Ment Health"},{"issue":"6","key":"5979_CR35","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1080\/13645579.2017.1281601","volume":"20","author":"G Guest","year":"2017","unstructured":"Guest G, et al. Comparing focus groups and individual interviews: findings from a randomized study. Int J Soc Res Methodol. 2017;20(6):693\u2013708.","journal-title":"Int J Soc Res Methodol"},{"key":"5979_CR36","volume-title":"Focus groups: a practical guide for applied research","author":"RA Krueger","year":"2014","unstructured":"Krueger RA. Focus groups: a practical guide for applied research. Sage publications; 2014."},{"key":"5979_CR37","doi-asserted-by":"publisher","DOI":"10.1177\/16094069241229777","volume":"23","author":"M Naeem","year":"2024","unstructured":"Naeem M, et al. Demystification and actualisation of data saturation in qualitative research through thematic analysis. Int J Qual Methods. 2024;23:16094069241229777.","journal-title":"Int J Qual Methods"},{"issue":"13","key":"5979_CR38","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1177\/1049732316654870","volume":"26","author":"L Birt","year":"2016","unstructured":"Birt L, et al. Member checking: a tool to enhance trustworthiness or merely a nod to validation? Qual Health Res. 2016;26(13):1802\u201311.","journal-title":"Qual Health Res"},{"issue":"2","key":"5979_CR39","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qual Res Psychol"},{"key":"5979_CR40","doi-asserted-by":"publisher","DOI":"10.4135\/9781036234386","volume-title":"Qualitative methods for health research","author":"J Green","year":"2018","unstructured":"Green J, Thorogood N. Qualitative methods for health research. 2018."},{"issue":"5","key":"5979_CR41","first-page":"545","volume":"41","author":"N Carter","year":"2014","unstructured":"Carter N. The use of triangulation in qualitative research. Number 5\/September. 2014;41(5):545\u20137.","journal-title":"Number 5\/September"},{"key":"5979_CR42","unstructured":"Organization, W.H., WHO guidelines for malaria, 13 august 2025. 2025."},{"key":"5979_CR43","unstructured":"Ochepo, P.A., Perceptions and attitudes to health-seeking delays for malaria treatment in Makurdi, Nigeria. 2022."},{"key":"5979_CR44","unstructured":"Afolabi, H.A., et al., Prediction of malaria outcomes using patients\u2019 demographical, environmental and clinical features. 2023."},{"issue":"1","key":"5979_CR45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12936-025-05246-4","volume":"24","author":"H Debash","year":"2025","unstructured":"Debash H, et al. Prevalence and associated factors of malaria among the displaced population in refugee camps in Africa: a systematic review and meta-analysis. Malar J. 2025;24(1):15.","journal-title":"Malar J"},{"issue":"2","key":"5979_CR46","doi-asserted-by":"publisher","first-page":"e199","DOI":"10.1016\/S2214-109X(20)30475-7","volume":"9","author":"C Gilmartin","year":"2021","unstructured":"Gilmartin C, et al. Seasonal malaria chemoprevention in the Sahel subregion of Africa: a cost-effectiveness and cost-savings analysis. Lancet Glob Health. 2021;9(2):e199\u2013208.","journal-title":"Lancet Glob Health"},{"key":"5979_CR47","doi-asserted-by":"publisher","first-page":"1119820","DOI":"10.3389\/fimmu.2023.1119820","volume":"14","author":"AB Tiono","year":"2023","unstructured":"Tiono AB, et al. Plasmodium falciparum infection coinciding with the malaria vaccine candidate BK-SE36 administration interferes with the immune responses in Burkinabe children. Front Immunol. 2023;14:1119820.","journal-title":"Front Immunol"},{"issue":"1","key":"5979_CR48","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1186\/1471-2334-13-535","volume":"13","author":"AB Tiono","year":"2013","unstructured":"Tiono AB, et al. Dynamics of malaria transmission and susceptibility to clinical malaria episodes following treatment of Plasmodium falciparum asymptomatic carriers: results of a cluster-randomized study of community-wide screening and treatment, and a parallel entomology study. BMC Infect Dis. 2013;13(1):535.","journal-title":"BMC Infect Dis"},{"issue":"12","key":"5979_CR49","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1093\/infdis\/jiw416","volume":"214","author":"TP Eisele","year":"2016","unstructured":"Eisele TP, et al. Short-term impact of mass drug administration with dihydroartemisinin plus piperaquine on malaria in Southern Province Zambia: a cluster-randomized controlled trial. J Infect Dis. 2016;214(12):1831\u20139.","journal-title":"J Infect Dis"},{"issue":"11","key":"5979_CR50","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1093\/cid\/ciaa471","volume":"72","author":"AM Samuels","year":"2021","unstructured":"Samuels AM, et al. Impact of community-based mass testing and treatment on malaria infection prevalence in a high-transmission area of western Kenya: a cluster randomized controlled trial. Clin Infect Dis. 2021;72(11):1927\u201335.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"5979_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020179","volume":"6","author":"LC Okell","year":"2011","unstructured":"Okell LC, et al. The potential contribution of mass treatment to the control of Plasmodium falciparum malaria. PLoS ONE. 2011;6(5):e20179.","journal-title":"PLoS ONE"},{"issue":"9","key":"5979_CR52","first-page":"008846","volume":"9","author":"MP Shah","year":"2021","unstructured":"Shah MP, et al. Mass drug administration for malaria. Cochrane Database Syst Rev. 2021;9(9):008846.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2 Suppl","key":"5979_CR53","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4269\/ajtmh.19-0673","volume":"103","author":"RW Steketee","year":"2020","unstructured":"Steketee RW, Miller JM, Kawesha EC. Implications of the MDA trial in Southern Province, Zambia, for malaria control and elimination. Am J Trop Med Hyg. 2020;103(2 Suppl):98.","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"5979_CR54","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12879-023-07991-w","volume":"23","author":"DC Echodu","year":"2023","unstructured":"Echodu DC, et al. Impact of population based indoor residual spraying with and without mass drug administration with dihydroartemisinin-piperaquine on malaria prevalence in a high transmission setting: a quasi-experimental controlled before-and-after trial in northeastern Uganda. BMC Infect Dis. 2023;23(1):72.","journal-title":"BMC Infect Dis"},{"key":"5979_CR55","unstructured":"Githinji, B.N., Preventing Malaria in Western Kenya through Educational Interventions and Treatment Combination of Indoor Residual Spraying with Insecticide Treated Mosquito Nets: An Integrated Review. 2021."},{"key":"5979_CR56","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ebiom.2016.10.032","volume":"13","author":"J Okebe","year":"2016","unstructured":"Okebe J, et al. The gametocytocidal efficacy of different single doses of Primaquine with Dihydroartemisinin-piperaquine in asymptomatic parasite carriers in The Gambia: A randomized controlled trial. EBioMedicine. 2016;13:348\u201355.","journal-title":"EBioMedicine"},{"key":"5979_CR57","unstructured":"Thiongane, M., Direct and Indirect Macroeconomic Effects of Malaria in Senegal."},{"key":"5979_CR58","unstructured":"Asante, F.A. and K. Asenso-Okyere, Economic burden of malaria in Ghana. Accra: Institute of Statistical, Social and Economic Research (ISSER), 2003: p. 1\u201381."},{"issue":"1","key":"5979_CR59","doi-asserted-by":"publisher","DOI":"10.3402\/gha.v7.23848","volume":"7","author":"MA Dalaba","year":"2014","unstructured":"Dalaba MA, et al. Does the national health insurance scheme in Ghana reduce household cost of treating malaria in the Kassena-Nankana districts? Glob Health Action. 2014;7(1):23848.","journal-title":"Glob Health Action"},{"issue":"1","key":"5979_CR60","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/1475-2875-12-307","volume":"12","author":"E Sicuri","year":"2013","unstructured":"Sicuri E, et al. The economic costs of malaria in children in three sub-Saharan countries: Ghana, Tanzania and Kenya. Malar J. 2013;12(1):307.","journal-title":"Malar J"},{"issue":"1","key":"5979_CR61","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12962-022-00376-x","volume":"20","author":"L Duval","year":"2022","unstructured":"Duval L, et al. Household costs associated with seeking malaria treatment during pregnancy: evidence from Burkina Faso and The Gambia. Cost Eff Resour Alloc. 2022;20(1):42.","journal-title":"Cost Eff Resour Alloc"},{"issue":"1","key":"5979_CR62","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12936-019-2877-9","volume":"18","author":"KA Baltzell","year":"2019","unstructured":"Baltzell KA, et al. \u201cWe were afraid of the lion that has roared next to us\u201d; community response to reactive focal mass drug administration for malaria in Eswatini (formerly Swaziland). Malar J. 2019;18(1):238.","journal-title":"Malar J"},{"issue":"1","key":"5979_CR63","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12936-023-04670-8","volume":"22","author":"G Newby","year":"2023","unstructured":"Newby G, et al. Testing and treatment for malaria elimination: a systematic review. Malar J. 2023;22(1):254.","journal-title":"Malar J"},{"issue":"3","key":"5979_CR64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0249080","volume":"16","author":"B Galatas","year":"2021","unstructured":"Galatas B, et al. Community acceptability to antimalarial mass drug administrations in Magude district, Southern Mozambique: a mixed methods study. PLoS ONE. 2021;16(3):e0249080.","journal-title":"PLoS ONE"},{"issue":"1","key":"5979_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-9-54","volume":"9","author":"GM Mubyazi","year":"2010","unstructured":"Mubyazi GM, et al. Women\u2019s experiences and views about costs of seeking malaria chemoprevention and other antenatal services: a qualitative study from two districts in rural Tanzania. Malar J. 2010;9(1):54.","journal-title":"Malar J"},{"issue":"1","key":"5979_CR66","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s12936-017-1982-x","volume":"16","author":"AS Ali","year":"2017","unstructured":"Ali AS, et al. Artemisinin combination therapy mass drug administration in a setting of low malaria endemicity: programmatic coverage and adherence during an observational study in Zanzibar. Malar J. 2017;16(1):332.","journal-title":"Malar J"},{"issue":"11","key":"5979_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0012664","volume":"18","author":"AO Forson","year":"2024","unstructured":"Forson AO, et al. Knowledge, perceptions, challenges and opportunities in achieving sustainable coverage of mass drug administration towards the control and elimination of Schistosomiasis and Soil Transmitted Helminths in hard-to-reach communities of Ghana. PLoS Negl Trop Dis. 2024;18(11):e0012664.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"5979_CR68","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12913-019-4070-9","volume":"19","author":"B Adhikari","year":"2019","unstructured":"Adhikari B, et al. Treatment-seeking behaviour for febrile illnesses and its implications for malaria control and elimination in Savannakhet Province, Lao PDR (Laos): a mixed method study. BMC Health Serv Res. 2019;19(1):252.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"5979_CR69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191707","volume":"13","author":"T Awine","year":"2018","unstructured":"Awine T, et al. Spatio-temporal heterogeneity of malaria morbidity in Ghana: analysis of routine health facility data. PLoS ONE. 2018;13(1):e0191707.","journal-title":"PLoS ONE"},{"issue":"2","key":"5979_CR70","doi-asserted-by":"publisher","first-page":"238146831989628","DOI":"10.1177\/2381468319896280","volume":"4","author":"E Sicuri","year":"2019","unstructured":"Sicuri E, et al. The costs of implementing vaccination with the RTS, S malaria vaccine in five sub-Saharan African countries. MDM policy & practice. 2019;4(2):2381468319896280.","journal-title":"MDM policy & practice"},{"issue":"6","key":"5979_CR71","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.4269\/ajtmh.19-0386","volume":"101","author":"N Sarma","year":"2019","unstructured":"Sarma N, et al. The economic burden of malaria: revisiting the evidence. Am J Trop Med Hyg. 2019;101(6):1405.","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"5979_CR72","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4269\/ajtmh.14-0254","volume":"93","author":"G Newby","year":"2015","unstructured":"Newby G, et al. Review of mass drug administration for malaria and its operational challenges. Am J Trop Med Hyg. 2015;93(1):125.","journal-title":"Am J Trop Med Hyg"},{"key":"5979_CR73","doi-asserted-by":"publisher","first-page":"98","DOI":"10.12688\/wellcomeopenres.12741.2","volume":"2","author":"DM Parker","year":"2017","unstructured":"Parker DM, et al. Scale up of a Plasmodium falciparum elimination program and surveillance system in Kayin State, Myanmar. Wellcome Open Res. 2017;2:98.","journal-title":"Wellcome Open Res"},{"issue":"2","key":"5979_CR74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002745","volume":"16","author":"L Von Seidlein","year":"2019","unstructured":"Von Seidlein L, et al. The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: a cluster randomised trial. PLoS Med. 2019;16(2):e1002745.","journal-title":"PLoS Med"},{"issue":"1","key":"5979_CR75","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12936-017-2158-4","volume":"17","author":"B Adhikari","year":"2018","unstructured":"Adhikari B, et al. Why do people participate in mass anti-malarial administration? Findings from a qualitative study in Nong District, Savannakhet Province, Lao PDR (Laos). Malar J. 2018;17(1):15.","journal-title":"Malar J"},{"issue":"9","key":"5979_CR76","doi-asserted-by":"publisher","first-page":"e591","DOI":"10.1016\/S1473-3099(24)00141-5","volume":"24","author":"PJ Rosenthal","year":"2024","unstructured":"Rosenthal PJ, et al. The emergence of artemisinin partial resistance in Africa: how do we respond? Lancet Infect Dis. 2024;24(9):e591\u2013600.","journal-title":"Lancet Infect Dis"},{"key":"5979_CR77","doi-asserted-by":"publisher","first-page":"59","DOI":"10.12688\/wellcomeopenres.12051.1","volume":"2","author":"L Kajeechiwa","year":"2017","unstructured":"Kajeechiwa L, et al. Community engagement for the rapid elimination of malaria: the case of Kayin State, Myanmar. Wellcome Open Res. 2017;2:59.","journal-title":"Wellcome Open Res"},{"key":"5979_CR78","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/s12936-016-1418-z","volume":"15","author":"J Nonvignon","year":"2016","unstructured":"Nonvignon J, et al. Cost-effectiveness of seasonal malaria chemoprevention in Upper West Region of Ghana. Malar J. 2016;15:367.","journal-title":"Malar J"},{"issue":"1","key":"5979_CR79","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1186\/s12936-017-2132-1","volume":"16","author":"ME Coldiron","year":"2017","unstructured":"Coldiron ME, Von Seidlein L, Grais RF. Seasonal malaria chemoprevention: successes and missed opportunities. Malar J. 2017;16(1):481.","journal-title":"Malar J"},{"issue":"10","key":"5979_CR80","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.pt.2003.08.003","volume":"19","author":"L von Seidlein","year":"2003","unstructured":"von Seidlein L, Greenwood BM. Mass administrations of antimalarial drugs. Trends Parasitol. 2003;19(10):452\u201360.","journal-title":"Trends Parasitol"},{"key":"5979_CR81","volume-title":"WHO Malaria Policy Advisory Group (MPAG) meeting, October 2022","author":"WH Organization","year":"2022","unstructured":"Organization WH. WHO Malaria Policy Advisory Group (MPAG) meeting, October 2022. World Health Organization; 2022."},{"issue":"1","key":"5979_CR82","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1016\/S1473-3099(16)30269-9","volume":"17","author":"NJ White","year":"2017","unstructured":"White NJ. Does antimalarial mass drug administration increase or decrease the risk of resistance? Lancet Infect Dis. 2017;17(1):e15\u201320.","journal-title":"Lancet Infect Dis"},{"issue":"9896","key":"5979_CR83","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/S0140-6736(13)60851-X","volume":"382","author":"LS Tusting","year":"2013","unstructured":"Tusting LS, et al. Socioeconomic development as an intervention against malaria: a systematic review and meta-analysis. Lancet. 2013;382(9896):963\u201372.","journal-title":"Lancet"},{"issue":"3","key":"5979_CR84","doi-asserted-by":"publisher","first-page":"650","DOI":"10.4269\/ajtmh.15-0554","volume":"94","author":"LS Tusting","year":"2016","unstructured":"Tusting LS, et al. Measuring socioeconomic inequalities in relation to malaria risk: a comparison of metrics in rural Uganda. Am J Trop Med Hyg. 2016;94(3):650.","journal-title":"Am J Trop Med Hyg"},{"issue":"10","key":"5979_CR85","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1046\/j.1365-3156.2003.01112.x","volume":"8","author":"A Noor","year":"2003","unstructured":"Noor A, et al. Defining equity in physical access to clinical services using geographical information systems as part of malaria planning and monitoring in Kenya. Trop Med Int Health. 2003;8(10):917\u201326.","journal-title":"Trop Med Int Health"},{"key":"5979_CR86","first-page":"315","volume":"3","author":"R Shretta","year":"2017","unstructured":"Shretta R, et al. Malaria elimination and eradication. Major Infect Dis. 2017;3:315\u201346.","journal-title":"Major Infect Dis"},{"issue":"1","key":"5979_CR87","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12936-020-03267-9","volume":"19","author":"R Shretta","year":"2020","unstructured":"Shretta R, et al. Estimating the risk of declining funding for malaria in Ghana: the case for continued investment in the malaria response. Malar J. 2020;19(1):196.","journal-title":"Malar J"},{"issue":"3","key":"5979_CR88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002380","volume":"14","author":"J Hemingway","year":"2016","unstructured":"Hemingway J, et al. Tools and strategies for malaria control and elimination: what do we need to achieve a grand convergence in malaria? PLoS Biol. 2016;14(3):e1002380.","journal-title":"PLoS Biol"},{"issue":"1","key":"5979_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jid.963","volume":"15","author":"K Hanson","year":"2003","unstructured":"Hanson K, et al. Expanding access to priority health interventions: a framework for understanding the constraints to scaling\u2010up. J Int Dev. 2003;15(1):1\u201314.","journal-title":"J Int Dev"},{"issue":"651","key":"5979_CR90","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn3256","volume":"14","author":"JM Cohen","year":"2022","unstructured":"Cohen JM, Okumu F, Moonen B. The fight against malaria: Diminishing gains and growing challenges. Sci Transl Med. 2022;14(651):eabn3256.","journal-title":"Sci Transl Med"},{"key":"5979_CR91","volume-title":"Global technical strategy for malaria 2016-2030","author":"WH Organization","year":"2015","unstructured":"Organization WH. Global technical strategy for malaria 2016-2030. World Health Organization; 2015."},{"key":"5979_CR92","volume-title":"Shrinking the malaria map: a prospectus on malaria elimination","author":"RG Feachem","year":"2009","unstructured":"Feachem RG, Phillips AA, Targett G. Shrinking the malaria map: a prospectus on malaria elimination. The Global Health Group, Global Health Sciences, University of California; 2009."}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-026-05979-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-026-05979-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-026-05979-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:02:51Z","timestamp":1781067771000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12936-026-05979-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5979"],"URL":"https:\/\/doi.org\/10.1186\/s12936-026-05979-w","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"31 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from Noguchi Memorial Institute for Medical Research Institutional Review Board (Noguchi-IRB), (005\/23\u201324). Written or thumb-printed informed consent was obtained from all participants prior to enrolment. Confidentiality was maintained by anonymising transcripts and restricting access to research staff only. The study adhered to the principles of the Declaration of Helsinki [\n                      \n                      ].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"235"}}